Narrative review / 2010
Review suggests serum 25(OH)D levels of 75 to 110 nmol/l provide optimal benefits for falls, fractures, and other endpoints without increasing health risks.
This study evaluated the benefits and risks of higher vitamin D doses and achieved 25(OH)D levels using double-blind RCTs and prospective cohort data. Based on RCTs for falls (n = 2,426) and non-vertebral fractures (n = 42,279), optimal benefits were observed at 700 to 1,000 IU/day or mean 25(OH)D between 75 and 110 nmol/l. Prospective cohort data on cardiovascular health and colorectal cancer suggested increased benefits with the highest categories evaluated (median 75 to 110 nmol/l). In 25 RCTs, oral vitamin D up to 100,000 IU/day or achieved 25(OH)D up to 643 nmol/l was not related to mean serum calcium, and levels of 75 to 110 nmol/l were reached in most RCTs with 1,800 to 4,000 IU/day without risk.
- Study type
- Benefit-risk review of RCTs and prospective cohorts
- Who was studied
- Participants across RCTs for falls (n = 2,426), fractures (n = 42,279), and other health outcomes
- What was measured
- Falls, non-vertebral fractures, cardiovascular health, colorectal cancer, and serum calcium
THE PAPER
Benefit-risk assessment of vitamin D supplementation.
Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Osteoporos Int, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.